𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PDB27 INSULIN GLARGINE AND NPH INSULIN-BASED REGIMENS REVEAL COMPARABLE TOTAL DIRECT TREATMENT COSTS IN TYPE 2 DIABETES PATIENTS.THE LONG-ACTING INSULIN GLARGINE VS. NPH INSULIN COST EVALUATION STUDY IN GERMANY (LIVE-DE)

✍ Scribed by T Scholten; R Holle; W Landgraf; A Spiesecke; H Hauner

Book ID
119597525
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
77 KB
Volume
11
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB54 COMPARISON OF TREATMENT COSTS BETW
PDB54 COMPARISON OF TREATMENT COSTS BETWEEN BASAL-SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE (GLA) AND BOT WITH INSULIN DETEMIR (DET) IN PATIENTS WITH TYPE 2 DIABETES (T2D): ECONOMIC EVALUATION BASED ON THE RESULTS OF THE INSULIN GLARGINE (LANTUS®) VERSUS INSULIN DETEMIR (LEVEMIR®) TREAT-TO-TARGET (L2T3) STUDY
✍ PK Schädlich; KC Koltermann; FW Dippel; EG Hagenmeyer; B Häussler 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB